catechin has been researched along with Metabolic Diseases in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 6 (54.55) | 2.80 |
| Authors | Studies |
|---|---|
| Hosseinzadeh, H; Imenshahidi, M; Mohajeri, SA; Mohsenzadeh, MS; Razavi, BM; Tabatabaee Yazdi, SA | 1 |
| James, A; Wang, K; Wang, Y | 1 |
| Fischerman, L; Fraga, CG; Galleano, M; Hid, EJ; Litterio, MC; Piotrkowski, B | 1 |
| Cao, F; Chen, R; Lai, X; Li, Q; Sun, L; Sun, S; Wu, D; Zhang, W | 1 |
| Chu, S; Hu, X; Huo, Y; Li, L; Li, M; Sun, S; Wan, C; Xu, J; Zhang, Y; Zhao, J | 1 |
| Chelliah, R; Daliri, EB; Javed, A; Oh, DH; Rubab, M; Shabbir, U | 1 |
| Eng, QY; Ramamurthy, S; Thanikachalam, PV | 1 |
| Cheng, C; Feng, ZJ; Jiang, H; Liu, CM; Ma, JQ; Sun, JM; Yang, W | 1 |
| Huang, XH; Hui, R; Li, SH; Wu, YJ; Xu, YL; Zheng, XX | 1 |
| Ideta, T; Kochi, T; Kubota, M; Miyazaki, T; Moriwaki, H; Sakai, H; Shimizu, M; Shirakami, Y | 1 |
| Das, NP; Koay, E; Ratty, AK | 1 |
6 review(s) available for catechin and Metabolic Diseases
| Article | Year |
|---|---|
Therapeutic Activity of Green Tea Epigallocatechin-3-Gallate on Metabolic Diseases and Non-Alcoholic Fatty Liver Diseases: The Current Updates.
Topics: Antioxidants; Catechin; Diabetes Mellitus, Type 2; Humans; Metabolic Diseases; Non-alcoholic Fatty Liver Disease; Obesity; Polyphenols; Tea | 2023 |
Regulation of Catechins in Uric Acid Metabolism Disorder Related Human Diseases.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Catechin; Humans; Metabolic Diseases; Uric Acid | 2020 |
Curcumin, Quercetin, Catechins and Metabolic Diseases: The Role of Gut Microbiota.
Topics: Catechin; Curcumin; Gastrointestinal Microbiome; Humans; Metabolic Diseases; Polyphenols; Quercetin | 2021 |
Molecular understanding of Epigallocatechin gallate (EGCG) in cardiovascular and metabolic diseases.
Topics: Animals; Anti-Inflammatory Agents; Camellia sinensis; Cardiovascular Agents; Cardiovascular Diseases; Catechin; Humans; Metabolic Diseases; Tea | 2018 |
Effects of green tea catechins with or without caffeine on glycemic control in adults: a meta-analysis of randomized controlled trials.
Topics: Adult; Blood Glucose; Caffeine; Camellia sinensis; Catechin; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Metabolic Diseases; Phytotherapy; Plant Extracts | 2013 |
Chemopreventive potential of green tea catechins in hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Catechin; Chemoprevention; Clinical Trials as Topic; Humans; Liver Neoplasms; Metabolic Diseases; Obesity; Tea | 2015 |
5 other study(ies) available for catechin and Metabolic Diseases
| Article | Year |
|---|---|
Potential role of green tea extract and epigallocatechin gallate in preventing bisphenol A-induced metabolic disorders in rats: Biochemical and molecular evidence.
Topics: Animals; Antioxidants; Benzhydryl Compounds; Catechin; Metabolic Diseases; Phenols; Plant Extracts; Rats; Tea | 2021 |
(-)-Epicatechin protects thoracic aortic perivascular adipose tissue from whitening in high-fat fed mice.
Topics: Adipocytes; Adipose Tissue; Adipose Tissue, White; Animals; Aorta, Thoracic; Blood Glucose; Catechin; Cholesterol; Diet, High-Fat; Dietary Fats; Dietary Supplements; Male; Metabolic Diseases; Mice, Inbred C57BL; NADPH Oxidase 2; Nitric Oxide Synthase Type III; Obesity; Plant Extracts; Tumor Necrosis Factor-alpha; Uncoupling Protein 1 | 2020 |
Comparative analysis of fecal metabolite profiles in HFD-induced obese mice after oral administration of huangjinya green tea extract.
Topics: Adipose Tissue, White; Animals; Blood Glucose; Camellia sinensis; Catechin; Diet, High-Fat; Feces; Humans; Insulin; Liver; Male; Metabolic Diseases; Mice; Mice, Inbred C57BL; Mice, Obese; Plant Extracts | 2020 |
Association of changes in ER stress-mediated signaling pathway with lead-induced insulin resistance and apoptosis in rats and their prevention by A-type dimeric epigallocatechin-3-gallate.
Topics: Animals; Apoptosis; Blood Glucose; Catechin; Cytochromes c; Dimerization; Diospyros; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Humans; Insulin; Insulin Resistance; Lead; Liver; Male; Metabolic Diseases; Oxidative Stress; Plant Extracts; Rats; Signal Transduction | 2017 |
In vivo effects of (+)-catechin on iron-overloaded rats.
Topics: Animals; Brain; Catechin; Iron; L-Lactate Dehydrogenase; Lipid Metabolism; Liver; Metabolic Diseases; Nitrilotriacetic Acid; Rats; Transferases | 1988 |